PanGen Biotech (Korea) Analysis

222110 Stock  KRW 6,000  290.00  4.61%   
PanGen Biotech is fairly valued with Real Value of 5766.25 and Hype Value of 6000.0. The main objective of PanGen Biotech stock analysis is to determine its intrinsic value, which is an estimate of what PanGen Biotech is worth, separate from its market price. There are two main types of PanGen Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect PanGen Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of PanGen Biotech's stock to identify patterns and trends that may indicate its future price movements.
The PanGen Biotech stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and PanGen Biotech's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PanGen Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

PanGen Stock Analysis Notes

About 33.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. PanGen Biotech Inc. operates as a specialized biologics company in South Korea. The company was founded in 1999 and is based in Suwon, South Korea. PanGen is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on PanGen Biotech please contact Jae Jang at 82 3 1733 9165 or go to http://www.pangen.com.

PanGen Biotech Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. PanGen Biotech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding PanGen Biotech or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
PanGen Biotech is way too risky over 90 days horizon
PanGen Biotech appears to be risky and price may revert if volatility continues
The company reported the revenue of 7.94 B. Net Loss for the year was (3.31 B) with profit before overhead, payroll, taxes, and interest of 1.35 B.
PanGen Biotech has accumulated about 8.9 B in cash with (3.32 B) of positive cash flow from operations.
Roughly 33.0% of the company shares are owned by insiders or employees

PanGen Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 59.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PanGen Biotech's market, we take the total number of its shares issued and multiply it by PanGen Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

PanGen Profitablity

PanGen Biotech's profitability indicators refer to fundamental financial ratios that showcase PanGen Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, PanGen Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, PanGen Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of PanGen Biotech's profitability requires more research than a typical breakdown of PanGen Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.92) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.82) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.82.

Technical Drivers

As of the 28th of November, PanGen Biotech holds the Semi Deviation of 2.74, coefficient of variation of 798.16, and Risk Adjusted Performance of 0.1044. PanGen Biotech technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.

PanGen Biotech Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. PanGen Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for PanGen Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

PanGen Biotech Outstanding Bonds

PanGen Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PanGen Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PanGen bonds can be classified according to their maturity, which is the date when PanGen Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

PanGen Biotech Predictive Daily Indicators

PanGen Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PanGen Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

PanGen Biotech Forecast Models

PanGen Biotech's time-series forecasting models are one of many PanGen Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PanGen Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About PanGen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how PanGen Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PanGen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PanGen Biotech. By using and applying PanGen Stock analysis, traders can create a robust methodology for identifying PanGen entry and exit points for their positions.
PanGen Biotech Inc. operates as a specialized biologics company in South Korea. The company was founded in 1999 and is based in Suwon, South Korea. PanGen is traded on Korean Securities Dealers Automated Quotations in South Korea.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding PanGen Biotech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Complementary Tools for PanGen Stock analysis

When running PanGen Biotech's price analysis, check to measure PanGen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PanGen Biotech is operating at the current time. Most of PanGen Biotech's value examination focuses on studying past and present price action to predict the probability of PanGen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PanGen Biotech's price. Additionally, you may evaluate how the addition of PanGen Biotech to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
CEOs Directory
Screen CEOs from public companies around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA